Skip to main content
SpringerLink
Log in

S1 Leitlinie: Molekulargenetische Diagnostik mit Hochdurchsatz-Verfahren der Keimbahn, beispielsweise mit Next-Generation Sequencing

  • Leitlinien und Stellungnahmen
  • Published:
medizinische genetik

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Calvo et al (2012) Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci Transl Med 4:118ra10

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. DellaMina et al (2015) Improving molecular diagnosis in epilepsy by a dedicated high-throughput sequencing platform. Eur J Hum Genet 23:354–364

    Article  CAS  Google Scholar 

  3. Eisenberger et al (2013) Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: the example of retinal dystrophies. PLoS ONE 8:e78496

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Gargis et al (2012) Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol 30:1033–1036

    Article  PubMed  CAS  Google Scholar 

  5. Gilissen et al (2014) Genome sequencing identifies major causes of severe intellectual disability. Nature 511:344–347

    Article  PubMed  CAS  Google Scholar 

  6. Green et al (2013) American College of Medical Genetics and Genomics: ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 15:565e574

    Article  CAS  Google Scholar 

  7. Matthijs et al (2016) Guidelines for diagnostic next-generation sequencing. Eur J Hum Genet 24:2–5

    Article  PubMed  CAS  Google Scholar 

  8. Mook et al (2013) Targeted sequence capture and GS-FLX Titanium sequencing of 23 hypertrophic and dilated cardiomyopathy genes: implementation into diagnostics. J Med Genet 50:614–626

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Nemeth et al (2013) Next generation sequencing for molecular diagnosis of neurological disorders using ataxias as a model. Brain 136:3106–3118

    Article  PubMed  PubMed Central  Google Scholar 

  10. Neveling et al (2013) A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases. Hum Mutat 34:1721–1726

    Article  PubMed  CAS  Google Scholar 

  11. Pugh et al (2014) The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med 16:601–608

    Article  PubMed  CAS  Google Scholar 

  12. Rehm HL (2013) Disease-targeted sequencing: a cornerstone in the clinic. Nat Rev Genet 14:295–300

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Rehm et al (2015) ClinGen – the clinical genome resource. N Engl J Med 372:2235–2242

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Richards et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and the Association of Molecular Pathology. Genet Med 17:405–424

    Article  PubMed  PubMed Central  Google Scholar 

  15. Schnekenberg et al (2014) Next-generation sequencing in childhood disorders. Arch Dis Child 99:284–290

    Article  PubMed  Google Scholar 

  16. Sikkema-Raddatz et al (2013) Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics. Hum Mutat 34:1035–1042

    Article  PubMed  CAS  Google Scholar 

  17. Srivastava S et al (2014) Clinical whole exome sequencing in child neurology practice. Ann Neurol 76:473–483

    Article  PubMed  Google Scholar 

  18. S2-Leitlinie „Humangenetische Diagnostik und genetische Beratung“, medizinische genetik 2011, 23:281-323, AWMF Registernummer 078 – 015

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

S1 Leitlinie: Molekulargenetische Diagnostik mit Hochdurchsatz-Verfahren der Keimbahn, beispielsweise mit Next-Generation Sequencing. medgen 30, 278–292 (2018). https://doi.org/10.1007/s11825-018-0189-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11825-018-0189-z

Search

Navigation